The rigid endoscopic lithotripsy devices market has seen considerable growth due to a variety of factors.
• The market for rigid endoscopic lithotripsy devices has seen robust growth in the past few years. The market is projected to expand from $4 billion in 2024 to $4.3 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%.
Factors contributing to the growth during the historical period include higher occurrence of kidney stones, increasing elderly population, decreased recovery time, lesser risk of complications, and a heightened awareness regarding kidney health.
The rigid endoscopic lithotripsy devices market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the rigid endoscopic lithotripsy devices market is predicted to witness substantial growth. It is anticipated to expand to $5.7 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.3%.
The ascent in market size during the forecast period can be credited to the increasing occurrence of urolithiasis, proactive government policies, escalating health-related spending, the rise in medical tourism, and a transition towards ambulatory procedures. Noteworthy trends projected for the forecast period encompass advanced lithotripsy technologies, technological advancements, partnership care models, integration into robotic systems, and ergonomic designs that prioritize user-friendliness.
The growth of the rigid endoscopic lithotripsy device market is anticipated to be fuelled by the escalating occurrence of bladder cancer. A malignant tumor that arises in the bladder's lining characterizes this type of cancer, leading to symptoms like blood-filled urine, frequent urination, and pelvic discomfort. The augmented incidence of bladder cancer can be attributed to factors such as higher exposure to carcinogens including smoking, industrial compounds, and environmental pollutants, coupled with an elderly population and advanced diagnostic techniques. Rigid endoscopic lithotripsy instruments play a critical role in managing bladder stones and other bladder cancer-associated complications like obstruction and irritation. They also assist in eliminating leftover tumors and ward off recurrence. As per a Cancer Facts & Figures 2024 report, published by The American Cancer Society Inc. (a non-profit organization based in the U.S.) in March 2024, bladder cancer diagnoses in the U.S. is speculated to surge from 81,180 new cases in 2022 to 83,190 in 2024. Thus, the proliferating occurrence of bladder cancer underpins the growth of the rigid endoscopic lithotripsy device market.
The rigid endoscopic lithotripsy devices market covered in this report is segmented –
1) By Type: Ultrasonic Lithotripsy, Ballistic Lithotripsy, Electrohydraulic Lithotripsy, Laser Lithotripsy
2) By Guidance System: Ureteroscopy, Cystoscopy, Percutaneous Nephrolithotomy
3) By Application: Hospitals, Clinics, Ambulatory Surgical Centers
4) By End-User: Adults, Pediatrics
Subsegments:
1) By Ultrasonic Lithotripsy: Standard Ultrasonic Lithotripsy Devices, Portable Ultrasonic Lithotripsy Devices, Ultrasonic Lithotripsy Systems with Imaging
2) By Ballistic Lithotripsy: Standard Ballistic Lithotripsy Devices, Pneumatic Ballistic Lithotripsy Devices, High-Energy Ballistic Lithotripsy Systems
3) By Electrohydraulic Lithotripsy: Standard Electrohydraulic Lithotripsy Devices, Miniaturized Electrohydraulic Lithotripsy Devices, Automated Electrohydraulic Lithotripsy Systems
4) By Laser Lithotripsy: Holmium Laser Lithotripsy Devices, Pulsed Dye Laser Lithotripsy Devices, Thulium Laser Lithotripsy Devices
Key players in the rigid endoscopic lithotripsy devices market are leveraging strategic alliances to foster product development and broaden their market footprint. Strategic alliances allow these companies to capitalize on each other's assets and expertise, culminating in mutual growth and prosperity. In a case in point, Karl Storz SE & Co. KG, a medical tech firm out of Germany, inked a deal with China's Well Lead Medical Co. Ltd., a manufacturer of medical catheters, in May 2023. The partnership aims to revamp endourology, boosting both patient care and surgical results. The alliance equips the market with the ClearPetra suction-evacuation ureteral access sheath, enhanced by KARL STORZ's endoscopic visualization devices, for a well-rounded urinary stone management strategy. This includes a one-of-a-kind contract for the distribution of the ClearPetra Stone-Removal System in America.
Major companies operating in the rigid endoscopic lithotripsy devices market are:
• EDAP TMS S.A.
• Siemens Healthineers
• Boston Scientific Corporation
• Olympus Corporation
• Smith & Nephew plc
• Coloplast Group
• Karl Storz SE & Co. KG
• Cook Group Incorporated
• ConMed Corporation
• Richard Wolf GmbH
• Dornier MedTech GmbH
• Thieme Group
• EMS Electro Medical Systems S.A.
• Allengers Medical Systems
• Rocamed S.A.M.
• Elmed Medical Systems
• Inceler Medikal Co. Ltd.
• LISA Laser Products
• Jena MedTech GmbH
• Biolitec AG
North America was the largest region in the rigid endoscopic lithotripsy devices market in 2024. The regions covered in the rigid endoscopic lithotripsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.